AKTX

Akari Therapeutics
AKTX

21 hedge funds and large institutions have $56M invested in Akari Therapeutics in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

more capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.1M
2
+$1.36M
3
+$321K
4
ACP
Acuta Capital Partners
California
+$200K
5
TI
Turner Investments
Pennsylvania
+$8.58K

Top Sellers

1
-$902K
2
-$389K
3
-$317K
4
SM
Sabby Management
Florida
-$314K
5
DCM
DAFNA Capital Management
California
-$55.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$15.5M
2
$7.12M
3
$6.7M
4
$6.1M
5
$4.98M
6
$3.16M
7
$2.91M
8
$2.66M
9
$2.14M
10
$1.89M
11
$856K
12
$629K
13
$446K
14
$345K
15
$315K
16
$235K
17
$13K
18
$6K
19
$5K
20
$4K